NovoCure Ltd (NVCR) — Institutional Holders, Q2 2026 (page 3)

217 institutional investment managers reported a NVCR position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.6B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 217. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

NVCR 13F holders ranked 201–217 of 217

Institutional investors reporting a position in NovoCure Ltd on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Parkside Financial Bank#201 · 90 sh$1.4K+100.0%
IFP Advisors#202 · 90 sh$1.4K+21.6%
Clearstead Advisors#203 · 66 sh$1.0KNew
HAZLETT, BURT & WATSON#204 · 65 sh$1.0K0.0%
Pinnacle Wealth Planning Services#205 · 62 sh$939.00-53.4%
Abound Wealth Management#206 · 54 sh$819.000.0%
TOMPKINS FINANCIAL#207 · 50 sh$758.000.0%
Investors Portfolio Services#208 · 39 sh$591.00New
Anchor Investment Management#209 · 25 sh$379.000.0%
Gen-Wealth Partners#210 · 19 sh$288.000.0%
Rakuten Securities#211 · 17 sh$258.000.0%
RAFFA WEALTH MANAGEMENT#212 · 16 sh$242.000.0%
Central Pacific Bank - Division#213 · 5 sh$76.00New
Golden State Wealth Management#214 · 3 sh$45.000.0%
Dunhill Financial#215 · 2 sh$32.000.0%
SALEM INVESTMENT COUNSELORS#216 · 2 sh$31.000.0%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#217 · 117,096 sh—-17.9%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.